PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 15, 1988New England Journal of Medicine379 citations

Clinical Implications of Prostaglandin and Thromboxane A2Formation

View Full Paper
JOJohn A. OatesGFGarret A. FitzGeraldRBRobert A. Branch

Key Result

Prostaglandins and thromboxane A2 are biologically active metabolites of arachidonic acid that participate in pathophysiologic processes across coronary, cerebral, and renal systems.

PICO

E
Exposure / Comparator
Prostaglandins and thromboxane A2

Abstract

(First of Two Parts)THE prostaglandins and thromboxane A2 are biologically active metabolites of arachidonic acid.1 , 2 Their actions and the pharmacologic agents that influence their formation affect almost every aspect of medical practice.The interactions of platelets with the vessel wall in catastrophic events in the coronary and cerebral arteries, as well as in diseases of smaller arterial vessels, have drawn attention to the participation of thromboxane A2 and prostacyclin (prostaglandin I2) in these pathophysiologic processes. Similarly, important medical consequences follow from the participation of prostaglandins in the pathophysiologic activities of the kidney, the mast cell, . . .

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Oates et al. (1988) reported a review. Prostaglandins and thromboxane A2 was evaluated. Prostaglandins and thromboxane A2 are biologically active metabolites of arachidonic acid that participate in pathophysiologic processes across coronary, cerebral, and renal systems.

synapsesocial.com/papers/6a6adb5101245da06ecb5132https://doi.org/10.1056/nejm198809153191106
Ask AI
Helpful
Bookmark
Share
View Full Paper